GB202408492D0 - Anti-alpha-synuclein antibody - Google Patents
Anti-alpha-synuclein antibodyInfo
- Publication number
- GB202408492D0 GB202408492D0 GBGB2408492.3A GB202408492A GB202408492D0 GB 202408492 D0 GB202408492 D0 GB 202408492D0 GB 202408492 A GB202408492 A GB 202408492A GB 202408492 D0 GB202408492 D0 GB 202408492D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- alpha
- synuclein antibody
- synuclein
- antibody
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
- C07K2317/33—Crossreactivity, e.g. for species or epitope, or lack of said crossreactivity
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
- C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/90—Immunoglobulins specific features characterized by (pharmaco)kinetic aspects or by stability of the immunoglobulin
- C07K2317/92—Affinity (KD), association rate (Ka), dissociation rate (Kd) or EC50 value
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Neurosurgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Immunology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Peptides Or Proteins (AREA)
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB2408492.3A GB202408492D0 (en) | 2024-06-13 | 2024-06-13 | Anti-alpha-synuclein antibody |
| PCT/EP2025/066637 WO2025257415A1 (en) | 2024-06-13 | 2025-06-13 | Anti-alpha-synuclein antibody |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB2408492.3A GB202408492D0 (en) | 2024-06-13 | 2024-06-13 | Anti-alpha-synuclein antibody |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB202408492D0 true GB202408492D0 (en) | 2024-07-31 |
Family
ID=91960978
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GBGB2408492.3A Ceased GB202408492D0 (en) | 2024-06-13 | 2024-06-13 | Anti-alpha-synuclein antibody |
Country Status (2)
| Country | Link |
|---|---|
| GB (1) | GB202408492D0 (en) |
| WO (1) | WO2025257415A1 (en) |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2016061389A2 (en) * | 2014-10-16 | 2016-04-21 | Genentech, Inc. | Anti-alpha-synuclein antibodies and methods of use |
| JP7217229B2 (en) * | 2016-11-15 | 2023-02-02 | ハー・ルンドベック・アクチエゼルスカベット | Agents, uses and methods for the treatment of synucleinopathies |
| AU2020350769A1 (en) * | 2019-09-20 | 2022-03-31 | Denali Therapeutics Inc. | Anti-alpha-synuclein antibodies and methods of use thereof |
-
2024
- 2024-06-13 GB GBGB2408492.3A patent/GB202408492D0/en not_active Ceased
-
2025
- 2025-06-13 WO PCT/EP2025/066637 patent/WO2025257415A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| WO2025257415A1 (en) | 2025-12-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB202305426D0 (en) | Antibodies | |
| GB202309981D0 (en) | Antibody | |
| GB202304512D0 (en) | Antibodies | |
| GB202217924D0 (en) | Antibodies | |
| GB202204159D0 (en) | Antibodies | |
| GB202504529D0 (en) | Antibody | |
| GB202417731D0 (en) | ZIP12 Antibody | |
| GB202408492D0 (en) | Anti-alpha-synuclein antibody | |
| GB202507044D0 (en) | Antibodies | |
| GB202416216D0 (en) | Antibodies | |
| GB202416214D0 (en) | Antibodies | |
| GB202413525D0 (en) | Antibodies | |
| GB202411940D0 (en) | Anti-CLEC12A Antibodies | |
| GB202410982D0 (en) | Antibodies | |
| GB202410983D0 (en) | Antibodies | |
| GB202409026D0 (en) | Antibodies | |
| GB202405480D0 (en) | Antibodies | |
| GB202404344D0 (en) | Antibodies | |
| GB202404343D0 (en) | Antibodies | |
| GB202400941D0 (en) | Antibodies | |
| GB202319122D0 (en) | Antibody | |
| GB202319149D0 (en) | Antibody | |
| IL315568A (en) | Zip12 antibody | |
| GB202206195D0 (en) | Antibody | |
| GB202401035D0 (en) | Alpha-synuclein antibody |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AT | Applications terminated before publication under section 16(1) |